Table 2.
Period A (1989-1993) 273 patients | Period B (2003-2007) 705 patients | P value | |
Male | 178 (65.2) | 418 (59.3) | 0.0892 |
Female | 95 (34.8) | 287 (40.7) | |
Age (yr) | |||
< 50 | 50 (19.2) | 91 (12.9) | < 0.0015 |
50-59 | 44 (16.9) | 154 (21.9) | |
60-69 | 103 (39.5) | 226 (32.1) | |
70-79 | 57 (21.8) | 185 (26.3) | |
≥ 80 | 7 (2.7) | 48 (6.8) | |
Total No. of polyps | 428 | 1265 | |
No. of polyps, mean ± SD | 1.6 ± 1 | 1.8 ± 1.3 | 0.0102 |
No. of polyps, median | 1 | 1 | |
Range | 1-6 | 1-14 | |
Dimensions | |||
< 5 mm | 114 (26.6) | 530 (41.9) | < 0.00005 |
5-9 mm | 228 (53.3) | 454 (35.9) | |
10-19 mm | 44 (10.3) | 191 (15.1) | |
20-29 mm | 23 (5.4) | 52 (4.1) | |
30-39 mm | 9 (2.1) | 25 (2) | |
40+ mm | 10 (2.3) | 13 (1) | |
Histopathological pattern | |||
Hyperplastic | 91 (33.6) | 438 (38.7) | < 0.00005 |
Mild/moderate dispalsia1 | 151 (55.7) | 597 (52.7) | |
Severe dysplasia2 | 27 (10) | 87 (7.7) | |
Others3 | 2 (0.7) | 10 (0.9) |
Tubular, mixed or villous adenoma with mild or low grade dysplasia;
Tubular, mixed or villous adenoma with severe dysplasia or cancer in situ or serrated adenoma;
Lymphatic lump, hamartoma, leiomyoma, anal human papilloma virus.